Blog
What I'll Be Watching When TripAdvisor Reports Earnings
Trading at multi-year lows, TripAdvisor (NASDAQ: TRIP) shares have had a tough slog, down nearly 20% so far in 2017. In its second-quarter earnings call, which will be held on August 9, investors will
A Light at the End of the Tunnel for Restaurant Stocks?
According to benchmarking data from MillerPulse, restaurant same-store sales increased 0.5% in June. Although the bump is small, it's not trivial as June marked the 2nd consecutive month of increasing
32 Millions Reasons Why Sirius XM Stock Hit at an 11-Year High
Sirius XM Holdings (NASDAQ: SIRI) began the trading week within spitting distance of an 11-year high, and it barreled through that ceiling on Thursday after posting blowout financial results. The last
Higher Prices and Volumes Drove Republic Services, Inc. to Its Best Quarter in 8 Years
Republic Services (NYSE: RSG) once again benefited from its ability to collect greater volumes even as it pushes through higher prices. Those dual fuels propelled revenue up 7.5% in the second quarter
The Only 2 Marijuana Stocks to Report a Profit in Their Latest Quarterly Results
Legal marijuana sales are soaring, and investors are relishing the industry's growth. A quick glance at the roughly one dozen largest marijuana stocks reveals that two-thirds have at least doubled in
Warren Buffett Didn't Buy-and-Hold These 3 Stocks, and It's Cost Him More Than $12 Billion
Warren Buffett is arguably the greatest investor of our generation. Since the 1950s, Buffett has managed to turn less than $10,000 into nearly $74 billion. In fact, he'd probably be worth $100 billion
Vertex Pharmaceuticals Incorporated Chugs Along
Vertex Pharmaceuticals (NASDAQ: VRTX) keeps chugging along, generating increased sales for its two cystic fibrosis drugs as it gains additional approvals to treat more patients, and producing clinical
Helmerich & Payne Couldn't Get Over the Profit Hurdle Last Quarter
As great as 2017 has been for the shale oil sector, with growing production that put rigs and other drilling equipment back online, and crews back to work, that hasn't necessarily translated to profit
Nestle Cuts Its Outlook as Sales Stall
Nestle (NASDAQOTH: NSRGY) leads the food industry, and its role atop the sector has left the company vulnerable to adverse business trends. In many of the countries Nestle serves, sluggish economic
Starbucks' Teavana Fails to Thrive in Struggling Malls
Few people deal with driving to a mall just to get a pretzel from Auntie Anne's or a cookie from Mrs. Fields, but in a packed shopping plaza, those chains serve hungry people. But as chains like Sears
Cliffs Natural Resources' U.S. Operations Get Overshadowed by a Weak International Market
The iron-ore market has been a fickle mistress as of late, and it has caused shares of Cliffs Natural Resources (NYSE: CLF) to bounce all over the place during the past year. This past quarter, the
3 Reasons for American Express Shareholders to Cheer
The American Express Company (NYSE: AXP) reported its 2017 second quarter earnings earlier this month and the results provided a lot for investors to be happy about. The company's adjusted revenue and
This High-Yield Stock Just Went on Sale
Shares of leading self-storage REIT Public Storage (NYSE: PSA) fell more than 5% after reporting disappointing second-quarter earnings, and dropped below the $200 mark for the first time since 2015
Pebblebrook Hotel Trust Earnings Continue Falling as Hotels Exit the Portfolio
Pebblebrook Hotel Trust (NYSE: PEB) closed the sale of another hotel during the quarter bringing its total to nine hotels since beginning its strategic disposition plan. However, with fewer hotels
Deeper Inside Intel Corporation's Client Computing Group Results
On July 27, microprocessor giant Intel (NASDAQ: INTC) reported its financial results for the second quarter of the year, offered guidance for the third quarter, and even raised its full-year revenue
3 Things Teradata Corp.'s Management Wants You to Know
Data analytics specialist Teradata (NYSE: TDC) reported second-quarter results early Thursday morning. Adjusted earnings came in 69% below the year-ago period's results at $0.22 per diluted share, and
3 Reasons Visa Just Delivered A Great Quarter ... Again
Right now, little seems to be able to slow down the world's largest payments network. A new CEO comes in and immediately faces a series of questions and concerns? No problem. The company must
Mindbody Earnings: Revenue Jumps 31% and Loss Narrows
Mindbody (NASDAQ: MB) reported second-quarter 2017 results after the market closed on Wednesday. The company -- which provides an online platform for wellness class providers that allows users to book
Abiomed, Inc. Starts Its Fiscal Year on a High Note
Abiomed (NASDAQ: ABMD), a medical-device company focused on minimally invasive heart pumps, reported its fiscal first-quarter earnings on Thursday, July 27. The company's results proved yet again that
Proto Labs Posts Solid Earnings, Driven by 3D Printing and CNC Machining
Proto Labs (NYSE: PRLB) released solid second-quarter 2017 earnings before the market opened on Thursday. The quick-turn manufacturing service provider's year-over-year revenue increased 9.4% and
Thinking About Getting an MBA? Here's What You Need to Consider
Whether you're looking to break into a new career or grow your current one, you may be toying with the idea of getting your MBA. Like any other advanced degree, an MBA could open the door to a world
Disruptor Alert: These 3 Companies are Changing Retail
The retail sector is a tricky one to invest in due to the ever-shifting balance between e-commerce and brick-and-mortar stores. Retailers that are growing often do so at anemic rates, while retailers
Cimpress N.V. Finishes an "Important" Year
Cimpress NV (NASDAQ: CMPR) announced fiscal fourth-quarter 2017 results on Wednesday after the market closed, showcasing reasonably strong revenue growth as the mass-customization specialist delivers
Main Street Capital: Risks Ahead of Earnings
Main Street Capital (NYSE: MAIN) is beloved for its historical underwriting performance, which has translated into industry-leading stock returns for its investors. Shares now trade at a 73% premium
Alkermes Continues to Execute
Alkermes (NASDAQ: ALKS), a biopharmaceutical company focused on diseases of the central nervous system, released its second-quarter earnings results on Thursday, July 27. The report showed that